We are live on ! Find out more
HHMI

Howard Hughes Medical Institute Portfolio holdings

AUM $416M
1-Year Est. Return 13.82%
This Fund
S&P 500
This Quarter Est. Return
-10.52%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$316M
AUM Growth
-$26.8M
Cap. Flow
+$11.5M
Cap. Flow %
3.63%
Top 10 Hldgs %
75.11%
Holding
30
New
3
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.02%
2 Financials 6.77%
3 Technology 6.56%
4 Consumer Staples 3.59%
5 Healthcare 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
K
26
DELISTED
Kellanova
K
$2.85M 0.9%
+53,250
New +$3.21M
COST icon
27
Costco
COST
$421B
$2.04M 0.65%
10,000
MMYT icon
28
MakeMyTrip
MMYT
$5.67B
$1.7M 0.54%
69,680
DVAX
29
DELISTED
Dynavax Technologies
DVAX
$195K 0.06%
21,355
TME icon
30
Tencent Music
TME
$13.7B
$0 ﹤0.01%
+28
New +$357

Similar funds

Howard Hughes Medical Institute's Q4 2018 Portfolio in Review

As of Q4 2018, Howard Hughes Medical Institute held 30 positions worth $316M, down 7.8% from $342M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Howard Hughes Medical Institute deployed $11.5M of net new capital in Q4 2018, opening 3 new positions. Its largest new stake was SolarWinds Corporation Common Stock: 526,230 shares worth $7.68M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9% of assets, down from 9.3% a quarter earlier, followed by Financials and Technology.

  • Howard Hughes Medical Institute's largest Q4 2018 buy was SolarWinds Corporation Common Stock: 526,230 shares worth $7.68M.
  • Howard Hughes Medical Institute's ten largest holdings make up 75% of its $316M portfolio in Q4 2018.
  • Howard Hughes Medical Institute opened 3 new positions and closed 0 in Q4 2018.
  • Howard Hughes Medical Institute's portfolio value fell 7.8% quarter-over-quarter to $316M.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2018, filed 13 Feb 2019.